Literature DB >> 20514531

Headache in multiple sclerosis.

Norman Putzki1, Zaza Katsarava.   

Abstract

Pain, including headache, is a frequent complaint of individuals with multiple sclerosis (MS). Prevalence of headache in patients with MS was reported to be higher than 50%, but it is uncertain if this is different than what is seen in the general population. Nonetheless, it is possible that MS and headaches are comorbid. Case reports illustrated that isolated MS lesions (eg, in "strategic" regions like the midbrain) may cause severe headaches often resembling migraine. Furthermore, the role of MS disease-modifying agents needs to be taken into consideration. Mode of action and side effect profiles differ, and treatment per se may sometimes trigger headache in patients with MS. Thorough evaluation of headache in patients with MS is crucial to optimize patient management to help improve quality of life.

Entities:  

Mesh:

Year:  2010        PMID: 20514531     DOI: 10.1007/s11916-010-0126-6

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  36 in total

1.  Migraine and probable migraine--results of FRAMIG 3, a French nationwide survey carried out according to the 2004 IHS classification.

Authors:  M Lantéri-Minet; D Valade; G Géraud; M H Chautard; C Lucas
Journal:  Cephalalgia       Date:  2005-12       Impact factor: 6.292

2.  Migraine and multiple sclerosis.

Authors:  S M Watkins; M Espir
Journal:  J Neurol Neurosurg Psychiatry       Date:  1969-02       Impact factor: 10.154

3.  The association of brainstem lesions with migraine-like headache: an imaging study of multiple sclerosis.

Authors:  Joey R Gee; Joyce Chang; Arthur B Dublin; Nazhiyath Vijayan
Journal:  Headache       Date:  2005-06       Impact factor: 5.887

Review 4.  The global burden of headache: a documentation of headache prevalence and disability worldwide.

Authors:  Lj Stovner; K Hagen; R Jensen; Z Katsarava; Rb Lipton; Ai Scher; Tj Steiner; J-A Zwart
Journal:  Cephalalgia       Date:  2007-03       Impact factor: 6.292

5.  Interferon treatment may trigger primary headaches in multiple sclerosis patients.

Authors:  L La Mantia; D D'Amico; A Rigamonti; N Mascoli; G Bussone; C Milanese
Journal:  Mult Scler       Date:  2006-08       Impact factor: 6.312

6.  Frequency of magnetic resonance imaging abnormalities in patients with migraine.

Authors:  B S Cooney; R I Grossman; R E Farber; J E Goin; S L Galetta
Journal:  Headache       Date:  1996 Nov-Dec       Impact factor: 5.887

7.  Migraine and tension-type headache in Croatia: a population-based survey of precipitating factors.

Authors:  R Zivadinov; K Willheim; D Sepic-Grahovac; A Jurjevic; M Bucuk; O Brnabic-Razmilic; G Relja; M Zorzon
Journal:  Cephalalgia       Date:  2003-06       Impact factor: 6.292

8.  Vascular headache: a presenting symptom of multiple sclerosis.

Authors:  M S Freedman; T A Gray
Journal:  Can J Neurol Sci       Date:  1989-02       Impact factor: 2.104

9.  Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

Authors:  L D Jacobs; D L Cookfair; R A Rudick; R M Herndon; J R Richert; A M Salazar; J S Fischer; D E Goodkin; C V Granger; J H Simon; J J Alam; D M Bartoszak; D N Bourdette; J Braiman; C M Brownscheidle; M E Coats; S L Cohan; D S Dougherty; R P Kinkel; M K Mass; F E Munschauer; R L Priore; P M Pullicino; B J Scherokman; R H Whitham
Journal:  Ann Neurol       Date:  1996-03       Impact factor: 10.422

10.  Pain syndromes in multiple sclerosis.

Authors:  D E Moulin; K M Foley; G C Ebers
Journal:  Neurology       Date:  1988-12       Impact factor: 9.910

View more
  3 in total

1.  Headache in multiple sclerosis: features and implications for disease management.

Authors:  David Tabby; Muhammad Hassan Majeed; Branden Youngman; Jessica Wilcox
Journal:  Int J MS Care       Date:  2013

2.  Moyamoya masquerading as relapsing remitting multiple sclerosis.

Authors:  Sydney Feldman; Megan Esch; Shiv Saidha
Journal:  Neurol Sci       Date:  2018-10-27       Impact factor: 3.307

3.  Flammer syndrome in multiple sclerosis: diagnostics, prediction, and personalization of treatments.

Authors:  Cihat Uzunköprü; Yeşim Beckmann
Journal:  EPMA J       Date:  2019-08-10       Impact factor: 6.543

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.